Insider Transactions in Q1 2022 at Albireo Pharma, Inc. (ALBO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
454
-0.97%
|
$13,620
$30.52 P/Share
|
|
Jan 24
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
418
-1.54%
|
$10,032
$24.72 P/Share
|
|
Jan 24
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
423
-2.6%
|
$10,152
$24.52 P/Share
|
|
Jan 24
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
3,684
-6.07%
|
$88,416
$24.88 P/Share
|
|
Jan 24
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
808
-1.37%
|
$19,392
$24.88 P/Share
|
|
Jan 24
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
416
-0.88%
|
$9,984
$24.88 P/Share
|
|
Jan 24
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
416
-1.21%
|
$9,984
$24.88 P/Share
|
|
Jan 24
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
1,688
-3.13%
|
$40,512
$24.97 P/Share
|
|
Jan 18
2022
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+31.4%
|
-
|
|
Jan 18
2022
|
Jason Duncan Chief Legal Officer and GC |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+37.05%
|
-
|
|
Jan 18
2022
|
Simon N.R. Harford CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+38.64%
|
-
|
|
Jan 18
2022
|
Michelle Graham Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+44.35%
|
-
|
|
Jan 18
2022
|
Martha J. Carter Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+39.85%
|
-
|
|
Jan 18
2022
|
Jan Mattsson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+26.74%
|
-
|
|
Jan 11
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
111
-0.87%
|
$2,775
$25.95 P/Share
|